Cedars-Sinai researchers awarded $1.

Related StoriesFranziska Michor called recipient of NYSCF – Robertson Stem Cell PrizeUS and German researchers team up to progress quality control of individual stem cellsSCT, Thermo Fisher Scientific collaborate to progress advancement of cardiac disease modelsThe author of more than 85 scientific publications, City is a well-known neuroimmunologist whose analysis targets understanding and treating neurologic disorders including Alzheimer’s disease, viral encephalitis, and stroke. He keeps the Ben Winters Seat in Regenerative Medicine. The support we receive from the California Institute for Regenerative Medication is crucial to developing the leading-edge remedies of tomorrow, said Clive Svendsen, Ph.D., a biopharmaceutical organization developing first in course collagenase-based products, today announced its financial outcomes for the fourth one fourth and full calendar year ended December 31, 2010.S. ‘We have become delighted that the European Commission provides granted advertising authorization of XIAPEX for the treating Dupuytren’s contracture in adult individuals with a palpable cord, and we anticipate Pfizer’s start of XIAPEX in European countries later this season.’ Financial Results: THE BUSINESS reported net gain of $0.december 31 1 million for the quarter ended, 2010, or $0.02 per talk about on a fundamental and diluted basis fully, in comparison to a net lack of $0.5 million or $0.09 per share on a basic and diluted basis fully, for the same period in ’09 2009.